Sitemap
Blog
- 05/24/2016 - Drug Makers to Prepare for Pharmacovigilance Reforms in Russia and Other EAEU Countries
- 07/06/2011 - European Medicines Agency listens to stakeholder expectations for pharmacovigilance reforms
- 07/01/2011 - Potential and Capabilities of the Clinical Research Sector
- 06/30/2011 - Pharmaceutical Outsourcing, Where Do You Draw the Line?
- 06/23/2011 - Global Drug Safety and Risk Management
- 06/15/2011 - Pharmacoepidemiology and Pharmacovigilance
- 05/30/2011 - FDA Compliance: Minimising Risk
- 05/19/2011 - Russia: Localisation vs. Isolation - Part Two
- 05/13/2011 - Russia: Needs to Invest in Cold Chain Infrastructure for Biopharma to Grow
- 05/11/2011 - 2010 In Review: Synopsis of Noteworthy FDA Approvals
- 04/22/2011 - 2010 pharmacovigilance legislation: strengthening the monitoring of medicines
- 04/19/2011 - EMA holds first stakeholder forum on the implementation of the new pharmacovigilance legislation
- 03/29/2011 - Orphan drug designation in the EU and the US
- 03/25/2011 - What Is The Value Of Outsourcing?
- 03/24/2011 - EMA launches clinical trial registry
- 03/15/2011 - Raising the Bar in Outsourcing
- 03/02/2011 - Russia: Localisation vs. Isolation - Part One
